Literature DB >> 16176963

Self-management training for people with chronic disease: a shared learning experience.

Julie H Barlow1, Georgina V Bancroft, Andy P Turner.   

Abstract

The lay-led, Chronic Disease Self-Management Course (CDSMC) is designed to train people in self-management. The present study focused on the experiences of a group of participants attending the CDSMC. Data were collected via interviews with nine participants four months and twelve months after attending the CDSMC. Results showed that participants appreciated the opportunity to share experiences in a reassuring environment. Goal setting was critical in making changes. The CDSMC provided participants with the confidence to select the self-management technique that would meet their needs at a given point in time.

Entities:  

Mesh:

Year:  2005        PMID: 16176963     DOI: 10.1177/1359105305057320

Source DB:  PubMed          Journal:  J Health Psychol        ISSN: 1359-1053


  13 in total

Review 1.  Conceptualisation of self-management intervention for people with early stage dementia.

Authors:  Faith Martin; Andrew Turner; Louise M Wallace; Nicola Bradbury
Journal:  Eur J Ageing       Date:  2012-11-07

Review 2.  Self-management education interventions for patients with cancer: a systematic review.

Authors:  Doris Howell; Tamara Harth; Judy Brown; Cathy Bennett; Susan Boyko
Journal:  Support Care Cancer       Date:  2017-01-05       Impact factor: 3.603

3.  Development of a Cancer Self-management Education Programme for Women with Breast Cancer at the End of Primary Treatment.

Authors:  Mai-Britt Bjørklund Ellegaard; Anders Bonde Jensen; Kirsten Lomborg
Journal:  J Cancer Educ       Date:  2019-10       Impact factor: 2.037

4.  An audiovisual information resource to assist in the transition from completion of potentially curative treatment for cancer through to survivorship: a systematic development process.

Authors:  A Karahalios; C Baravelli; M Carey; P Schofield; A Pollard; S Aranda; J Franklin; M Jefford
Journal:  J Cancer Surviv       Date:  2007-09       Impact factor: 4.442

5.  Effectiveness of a patient self-management programme for breast cancer as a chronic illness: a non-randomised controlled clinical trial.

Authors:  Siew Yim Loh; Tanya Packer; Karuthan Chinna; Kia Fatt Quek
Journal:  J Cancer Surviv       Date:  2013-03-22       Impact factor: 4.442

6.  Translating patient education theory into practice: developing material to address the cardiovascular education needs of people with rheumatoid arthritis.

Authors:  Holly John; Elizabeth D Hale; Paul Bennett; Gareth J Treharne; Douglas Carroll; George D Kitas
Journal:  Patient Educ Couns       Date:  2010-07-17

7.  Cancer survivors' self-efficacy to self-manage in the year following primary treatment.

Authors:  C Foster; M Breckons; P Cotterell; D Barbosa; L Calman; J Corner; D Fenlon; R Foster; C Grimmett; A Richardson; P W Smith
Journal:  J Cancer Surviv       Date:  2014-07-16       Impact factor: 4.442

8.  Making and maintaining lifestyle changes after participating in group based type 2 diabetes self-management educations: a qualitative study.

Authors:  Marit B Rise; Anneli Pellerud; Lisbeth Ø Rygg; Aslak Steinsbekk
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

9.  Rationale of the BREAst cancer e-healTH [BREATH] multicentre randomised controlled trial: an internet-based self-management intervention to foster adjustment after curative breast cancer by decreasing distress and increasing empowerment.

Authors:  Sanne W van den Berg; Marieke F M Gielissen; Petronella B Ottevanger; Judith B Prins
Journal:  BMC Cancer       Date:  2012-09-07       Impact factor: 4.430

10.  Time's up. descriptive epidemiology of multi-morbidity and time spent on health related activity by older Australians: a time use survey.

Authors:  Tanisha Jowsey; Ian S McRae; Jose M Valderas; Paul Dugdale; Rebecca Phillips; Robin Bunton; James Gillespie; Michelle Banfield; Lesley Jones; Marjan Kljakovic; Laurann Yen
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.